Chiefs have pitched a child welfare reform plan that divests control from government and gives power to new First Nations led ...

If you are wondering whether Veeva Systems at around US$209.98 is a fair price, a premium, or an opportunity, this article is designed to walk you through that question clearly. The stock has seen ...

If you are trying to work out whether QXO is still good value or already pricing in a lot of optimism, you will want to look past the headline share price and into what the numbers actually say. Over ...

Cancer is now a major cause of premature mortality in every region,1,2 yet the global health system still cannot answer basic questions about access to essential cancer medicines. Spending on oncology ...

Eversense 365 is the world’s first and only one year CGM, which was approved by the United States (US) Food and Drug Administration in September of 2024 and launched across the country in October of ...